Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
KB Home
KBH
D.R. Horton
DHI
Meritage Homes
MTH
US Stock MarketDetailed Quotes
SANA Sana Biotechnology
- 1.570
- -0.040-2.48%
Trading Dec 31 12:26 ET
350.53MMarket Cap-1.12P/E (TTM)
1.645High1.540Low622.72KVolume1.610Open1.610Pre Close990.61KTurnover0.48%Turnover RatioLossP/E (Static)223.27MShares12.00052wk High1.20P/B205.54MFloat Cap1.52052wk Low--Dividend TTM130.91MShs Float44.600Historical High--Div YieldTTM6.52%Amplitude1.520Historical Low1.590Avg Price1Lot Size
About Sana Biotechnology Company
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
Company Profile
SymbolSANA
Company NameSana Biotechnology
Listing DateFeb 4, 2021
Issue Price25.00
Founded2018
CEODr. Steven D. Harr, M.D.
MarketNASDAQ
Employees328
Fiscal Year Ends12-31
Address188 East Blaine Street,Suite 400
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98102
Phone1-206-701-7914
Websitehttp://www.sana.com
Company Executives
- Name
- Position
- Salary
- Dr. Steven D. Harr, M.D.
- President, Acting Principal Financial Officer, Chief Executive Officer and Director
- 2.67M
- Susan Wyrick
- Acting Chief Financial Officer, Acting Treasurer, and Acting Principal Accounting Officer
- --
- Christian Hordo
- Executive Vice President and Chief Business Officer
- --
- Bernard J. Cassidy
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Hans Edgar Bishop
- Chairman of the Board
- 354.80K
- Dr. Richard C. Mulligan, PhD
- Executive Vice Chairman of the Board
- --
- Dr. Patrick Y. Yang, PhD
- Independent Director
- 299.80K
- Dr. Joshua H. Bilenker, M.D.
- Independent Director
- 299.80K
- Dr. Alise S. Reicin, M.D.
- Independent Director
- 302.30K
- Mary Agnes Wilderotter
- Independent Director
- 314.80K
- Michelle Seitz, C.F.A.
- Independent Director
- 314.80K
- Dr. Douglas G. Cole, M.D.
- Independent Director
- 302.30K
- Robert Taylor Nelsen
- Independent Director
- 294.80K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.